Schally; Andrew V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Schally; Andrew V..The latest application filed is for "ghrh antagonists for use in a method of treating sarcoidosis".
Company Profile
0.25.21
- Schally; Andrew V. - Miami Beach FL
- Schally; Andrew V. - Miami FL
- Schally; Andrew V - Miami Beach FL US
- Schally; Andrew V. - US
- Schally; Andrew V. - Metairie LA
- Schally; Andrew V. - Metarie LA
- Schally; Andrew V. - New Orleans LA
Patent Activity
| Patent | Date |
|---|---|
| Ghrh Antagonists For Use In A Method Of Treating Sarcoidosis App 20220143149 - Mirsaeidi; Mehdi ; et al. | 2022-05-12 |
| Treating Inflammatory Lung Disease App 20220000983 - Jackson; Robert M. ; et al. | 2022-01-06 |
| Growth Hormone-Releasing Hormone Antagonists and Uses Thereof App 20210395327 - Jackson; Robert M. ; et al. | 2021-12-23 |
| GHRH agonists for the treatment of ischemic disorders Grant 9,855,312 - Schally , et al. January 2, 2 | 2018-01-02 |
| GHRH agonists for islet cell transplantation and function and the treatment of diabetes Grant 9,393,271 - Schally , et al. July 19, 2 | 2016-07-19 |
| Novel N- And C-terminal Substituted Antagonistic Analogs Of Gh-rh App 20160166652 - SCHALLY; Andrew V. ; et al. | 2016-06-16 |
| N- and C-terminal substituted antagonistic analogs of GH-RH Grant 9,260,504 - Schally , et al. February 16, 2 | 2016-02-16 |
| Novel Gh-rh Analogs With Potent Agonistic Effects App 20150274798 - SCHALLY; Andrew V. ; et al. | 2015-10-01 |
| GH-RH analogs with potent agonistic effects Grant 9,079,974 - Schally , et al. July 14, 2 | 2015-07-14 |
| Methods For Treating Cancer With Ghrh Agonists App 20150174207 - SCHALLY; Andrew V. ; et al. | 2015-06-25 |
| Compositions And Methods Of Treating Alzheimer's Disease App 20150166617 - Schally; Andrew V. ; et al. | 2015-06-18 |
| Agonists of growth hormone releasing hormone as effectors for survival and proliferation of pancreatic islets Grant 8,980,249 - Schally , et al. March 17, 2 | 2015-03-17 |
| Novel N- And C-terminal Substituted Antagonistic Analogs Of Gh-rh App 20140206836 - SCHALLY; Andrew V. ; et al. | 2014-07-24 |
| Ghrh Agonists For Islet Cell Transplantation And Function And The Treatment Of Diabetes App 20140193378 - SCHALLY; Andrew V. ; et al. | 2014-07-10 |
| Ghrh Agonists For The Treatment Of Ischemic Disorders App 20140179604 - SCHALLY; Andrew V. ; et al. | 2014-06-26 |
| N- and C- terminal substituted antagonistic analogs of GH-RH Grant 8,691,942 - Schally , et al. April 8, 2 | 2014-04-08 |
| Cardioprotective Effects Of Ghrh Agonists App 20140057847 - SCHALLY; Andrew V. ; et al. | 2014-02-27 |
| Novel GH-RH analogs with potent agonistic effects App 20140058068 - Schally; Andrew V. ; et al. | 2014-02-27 |
| Novel N- and C- terminal substituted antagonistic analogs of GH-RH App 20130261055 - Schally; Andrew V. ; et al. | 2013-10-03 |
| Acceleration Of Wound Healing By Growth Hormone Releasing Hormone And Its Agonists App 20130261058 - Schally; Andrew V. ; et al. | 2013-10-03 |
| Cardioprotective effects of GHRH agonists Grant 8,507,433 - Schally , et al. August 13, 2 | 2013-08-13 |
| Agonists Of Growth Hormone Releasing Hormone As Effectors For Survival And Proliferation Of Pancreatic Islets App 20130195807 - Schally; Andrew V. ; et al. | 2013-08-01 |
| Antioxidant activity of GH-RH Antagonists App 20100152114 - Schally; Andrew V. ; et al. | 2010-06-17 |
| Antagonistic analogs of GH RH (2003) Grant 7,452,865 - Schally , et al. November 18, 2 | 2008-11-18 |
| Antagonistic analogs of gh rh (2003) App 20070042950 - Schally; Andrew V. ; et al. | 2007-02-22 |
| Antagonistic analogs of GH-RH inhibiting IGF-I and -II Grant 7,026,281 - Schally , et al. April 11, 2 | 2006-04-11 |
| Targeted cytotoxic anthracycline analogs Grant 5,843,903 - Schally , et al. December 1, 1 | 1998-12-01 |
| Highly potent agonists of growth hormone releasing hormone Grant 5,792,747 - Schally , et al. August 11, 1 | 1998-08-11 |
| LHRH analogues with cytotoxic moieties at the sixth position Grant 5,258,492 - Schally , et al. * November 2, 1 | 1993-11-02 |
| LHRH antagonists Grant 5,198,533 - Schally , et al. * March 30, 1 | 1993-03-30 |
| Process for increasing the antagonistic effect of peptidic compounds on hormone-dependent diseases Grant 4,835,139 - Tice , et al. May 30, 1 | 1989-05-30 |
| LHRH antagonists Grant 4,800,191 - Schally , et al. January 24, 1 | 1989-01-24 |
| Biologically active lysine containing octapeptides Grant 4,725,577 - Schally , et al. February 16, 1 | 1988-02-16 |
| Biologically active octapeptides Grant 4,650,787 - Schally , et al. March 17, 1 | 1987-03-17 |
| Anorexigenic peptides Grant 4,328,134 - Schally , et al. May 4, 1 | 1982-05-04 |
| LH-RH Antagonists Grant 4,317,815 - Coy , et al. March 2, 1 | 1982-03-02 |
| Somatostatin analogs having a substituted tryptophyl residue in position eight Grant 4,224,199 - Meyers , et al. September 23, 1 | 1980-09-23 |
| [D-Trp.sup.6 ]-LH-RH and intermediates therefor Grant 4,010,125 - Schally , et al. March 1, 1 | 1977-03-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 